.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Deloitte
Federal Trade Commission
Johnson and Johnson
Citi
QuintilesIMS
Moodys
Healthtrust
Chubb
Harvard Business School

Generated: July 26, 2017

DrugPatentWatch Database Preview

Lidocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine hydrochloride and what is the scope of lidocaine hydrochloride freedom to operate?

Lidocaine hydrochloride
is the generic ingredient in thirty-five branded drugs marketed by Intl Medication, Fresenius Kabi Usa, Hospira, West-ward Pharms Int, Belmora Llc, Abraxis Pharm, Vintage, Bel Mar, Miles, Hi Tech Pharma, Powder Pharms, Oak Pharms, Astrazeneca, G And W Labs Inc, Akorn, Carlisle, Elkins Sinn, Watson Labs, Pharmaton, Bionpharma Inc, B Braun, Kendall Il, Gd Searle Llc, Watson Labs Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Meridian Medcl Techn, Luitpold, Abbott, Baxter Hlthcare, Luitpold Pharms Inc, Wockhardt, Actavis Mid Atlantic, Dentsply Pharm, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Sagent Pharms, Teligent Pharma Inc, and Pfizer, and is included in ninety-eight NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has twenty-one patent family members in twelve countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty-six suppliers are listed for this compound.

Summary for Generic Name: lidocaine hydrochloride

Tradenames:35
Patents:6
Applicants:41
NDAs:98
Drug Master File Entries: see list29
Suppliers / Packagers: see list46
Bulk Api Vendors: see list32
Clinical Trials: see list3,089
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lidocaine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc
ANESTACON
lidocaine hydrochloride
JELLY;TOPICAL080429-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION080377-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018461-004Feb 22, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
B Braun
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018967-001Mar 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION088325-001Jul 31, 1984APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546Particle cassettes and processes therefor► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine hydrochloride

Country Document Number Estimated Expiration
South Korea20160141717► Subscribe
World Intellectual Property Organization (WIPO)2008014036► Subscribe
Japan2000507131► Subscribe
United Kingdom9605690► Subscribe
World Intellectual Property Organization (WIPO)2008135719► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Johnson and Johnson
Fuji
Moodys
US Department of Justice
Medtronic
Queensland Health
Mallinckrodt
Farmers Insurance
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot